Dr Reddy’s Launches Cancer Drug In Canada
The launch of Reddy-Lenalidomide has been announced by Dr Reddy’s Laboratories Ltd. on Thursday. This is a generic equivalent to Revlimid (lenalidomide) capsules, in the Canadian market following approval from…
Share